Association of Progressive CD4+ T Cell Decline in SIV Infection with the Induction of Autoreactive Antibodies by Kuwata, Takeo et al.
Association of Progressive CD4
+ T Cell Decline in SIV
Infection with the Induction of Autoreactive Antibodies
Takeo Kuwata
1,2, Yoshiaki Nishimura
2, Sonya Whitted
2, Ilnour Ourmanov
2, Charles R. Brown
2,Q u e
Dang
2, Alicia Buckler-White
2, Ranjini Iyengar
2, Jason M. Brenchley
2, Vanessa M. Hirsch
2*
1Priority Organization for Innovation and Excellence, Kumamoto University, Kumamoto, Japan, 2Laboratory of Molecular Microbiology, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America
Abstract
The progressive decline of CD4
+ T cells is a hallmark of disease progression in human immunodeficiency virus (HIV) and
simian immunodeficiency virus (SIV) infection. Whereas the acute phase of the infection is dominated by virus-mediated
depletion of memory CD4
+ T cells, chronic infection is often associated with a progressive decline of total CD4
+ T cells,
including the naı ¨ve subset. The mechanism of this second phase of CD4
+ T cell loss is unclear and may include immune
activation–induced cell death, immune-mediated destruction, and regenerative or homeostatic failure. We studied patterns
of CD4
+ T cell subset depletion in blood and tissues in a group of 20 rhesus macaques inoculated with derivatives of the
pathogenic SIVsmE543-3 or SIVmac239. Phenotypic analysis of CD4
+ T cells demonstrated two patterns of CD4
+ T cell
depletion, primarily affecting either naı ¨ve or memory CD4
+ T cells. Progressive decline of total CD4
+ T cells was observed
only in macaques with naı ¨ve CD4
+ T cell depletion (ND), though the depletion of memory CD4
+ T cells was profound in
macaques with memory CD4
+ T cell depletion (MD). ND macaques exhibited lower viral load and higher SIV-specific
antibody responses and greater B cell activation than MD macaques. Depletion of naı ¨ve CD4
+ T cells was associated with
plasma antibodies autoreactive with CD4
+ T cells, increasing numbers of IgG-coated CD4
+ T cells, and increased incidence of
autoreactive antibodies to platelets (GPIIIa), dsDNA, and phospholipid (aPL). Consistent with a biological role of these
antibodies, these latter antibodies were accompanied by clinical features associated with autoimmune disorders,
thrombocytopenia, and catastrophic thrombotic events. More importantly for AIDS pathogenesis, the level of autoreactive
antibodies significantly correlated with the extent of naı ¨ve CD4
+ T cell depletion. These results suggest an important role of
autoreactive antibodies in the CD4
+ T cell decline observed during progression to AIDS.
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Introduction
Progressive CD4
+ T cell decline in human immunodeficiency
virus (HIV) infection, the slow but persistent loss of both naı ¨ve and
memory CD4
+ T cells [1–3], is an important marker of
progression to AIDS. The mechanism of chronic CD4
+ T cell
depletion is not clear since the number of infected cells at any one
point in time would not seem to account for the extent of CD4
+ T
cell loss. Such progressive decline in CD4
+ T cells is also observed
in some but not all simian immunodeficiency virus (SIV) macaque
models for AIDS [4–6]. Recent studies have shown that selective
memory CD4
+ T cell depletion is characteristically observed
during the acute stage of SIV- and HIV-infection, presumably
through direct killing of CCR5
+CD4
+ target cells [7–12].
However, early mucosal depletion of memory CD4
+ T cells is
also observed in nonpathogenic infection of natural African
monkeys such as African green monkeys and sooty mangabeys
[13,14].
Additional events are therefore required for AIDS pathogenesis
in the pathogenic SIV/macaque model and in HIV-infected
humans. Many host-mediated mechanisms have been suggested
for the depletion of CD4
+ T cells, including failure of regeneration
and homeostasis, immune activation-induced cell death, autoim-
mune destruction and disruption of the lymphoid microarchitec-
ture by collagen deposition [15–18]. Although HIV-1 is named for
the immunodeficiency it induces, chronic immune activation is
also a characteristic feature of this disease [1,6,19–22]. The
chronic stages of HIV-infection, as well as pathogenic SIV
infection, are characterized by generalized lymphadenopathy,
immune activation of T-lymphocytes, hyper-gammaglobulinemia,
and polyclonal B cell hyperactivity. SIV infection of natural host
species, such as sooty mangabeys and African green monkeys, is
not associated with the abnormal chronic immune activation and
the accelerated T cell turnover seen in pathogenic models,
suggesting a critical role of immune activation in the pathogenesis
of AIDS [23,24].
Chronic SIV-infection of macaques provides a relevant and
useful model to explore the mechanisms for progressive CD4
+ T
cell loss in AIDS pathogenesis. Earlier studies in our lab
demonstrated that the rate of disease progression was associated
with distinct patterns of CD4
+ T cell decline in SIV-infected
macaques [6]. SIV-infected macaques that progress rapidly
PLoS Pathogens | www.plospathogens.org 1 April 2009 | Volume 5 | Issue 4 | e1000372without adaptive immune responses show the most severe memory
CD4
+ T cell loss with relative preservation of naı ¨ve cells [6,25–30].
In contrast, a progressive loss of total CD4
+ T cells including naı ¨ve
cells is observed during chronic SIV infection of conventional
progressors [4–6], as is also observed in HIV-1 patients [1–3].
Since the level of CD4
+ T cells in the blood of HIV-infected
patients is predictive of the onset of AIDS, we wished to explore
this second pattern in greater detail. In this study, we used a SIV/
macaque model to explore the mechanisms of CD4
+ T cell
depletion, and found that the progressive loss of CD4
+ T cells was
associated with antibodies that reacted with CD4
+ T cells. This
pattern of depletion was observed in a subset of animals with
intense immune activation and autoimmune manifestations
consistent with a functional role of these antibodies in the
observed CD4 depletion.
Results
Two Patterns of CD4
+ T Cell Depletion in SIV Infection of
Rhesus Macaques
To clarify the mechanism of progressive CD4
+ T cell decline in
the SIV/ rhesus macaque model, we analyzed CD4
+ T cell naı ¨ve
and memory subsets in retrospective samples of blood and various
tissues of twenty macaques infected with derivatives of the
pathogenic SIVsmE543-3 or SIVmac239 (Table 1). We found
that the pattern of depletion of naı ¨ve and memory CD4
+ T cell
subsets in terminal blood samples differed substantially, showing
two patterns of depletion, predominantly affecting either naı ¨ve or
memory CD4
+ T cells (Figure 1A and Figure S1). Animals were
classified at death as either ND (naı ¨ve depleted) or MD (memory
depleted) based upon the ratio of naı ¨ve to memory CD4
+ T cells in
the blood (Figure 1B) using a ratio of less than three to identify ND
macaques. This classification was confirmed by the naı ¨ve to
memory ratio in the peripheral lymph nodes (PLN) and spleen of
12 animals (Figure 1B). Twelve macaques showed primarily naı ¨ve
Author Summary
Despite intensive study, the mechanisms of CD4
+ T cell
depletion in human immunodeficiency virus (HIV) infection
remain elusive. The identification of the CD4 receptor as
the primary receptor for HIV seemed initially to explain the
loss of CD4
+ T cell lymphocytes in AIDS. However, the
number of infected cells at any point in time is insufficient
to explain the extent of loss and the slow disease course.
While virus-induced cell death might explain early loss of
CD4
+ T cells, such mechanisms were unlikely to explain the
slow depletion over the long period leading to AIDS. Thus,
mechanisms related to the intense immune activation, also
a hallmark of HIV infection, were proposed. Here, we
studied a surrogate model for AIDS, simian immunodefi-
ciency (SIV) infection of rhesus macaques, to explore the
mechanisms of this second phase of depletion. We found
that animals that exhibited slow, progressive loss of CD4
+
T cells had circulating antibodies that reacted with CD4
+ T
cells and that the levels of these antibodies correlated with
the extent of CD4
+ T cell depletion. These results suggest
that autoimmune destruction of CD4
+ T cells represents a
valid mechanism to explore in the pathogenesis of CD4
+ T
cell loss in AIDS.
Table 1. Clinical and Pathological Outcome of SIV-Infected Macaques
Group Macaque SIV Inoculum
a Survival (wpi) Major Pathologic Findings
ND H596 E543-3 23 Thrombus (pulmonary artery), LDN
H711 E543-3+H635FC 26 Mesenteric root torsion, SIVE, GN, LDN
H709 H635FC 41 Thrombus (L. ventricle), enteritis, LDN, SIVE
CK61 E543-3 56 SIVE, enteritis, cholangitis, LDN
H589 mac239 60 Enteritis with IA, LDN
H723 H635FC 68 Thrombus, bacterial endocarditis, LDN
H679 E543-3 73 Renal abscesses, peritonitis, LPD, LDN
XGE E543-3 77 Thrombus (pulmonary), bacterial pneumonia, IA, LDN
H461 E543-3 78 Bacterial endocarditis with sepsis, LDN
H714 H635FC 85 Thrombus (vena cava), LDN
H725 Plasma 86 Disseminated lymphoma, protozoal enteritis, LDN
H704 H635FC 142 Thrombus (Pulmonary artery), LDN
MD CK2K E543-3 15 SIVE, GN, enteritis
H717 Plasma 16 SIVE, SIVP, enteritis
H713 E543-3+H635FC 27 SIVE, protozoal enteritis
95D139 mac239 28 Enteritis, nephritis (CMV), SIVE
CK2F E543-3 31 SIVE, SIVP, GN, enteritis
CK7E E543-3 39 SIVE, SIVP, GN, enteritis
H718 Plasma 51 SIVE, SIVP, Pneumocystis pneumonia
H712 E543-3+H635FC 60 SIVP, SIVE, enteritis, LDN
aMacaques were inoculated with one of five different inocula, SIVsmE543-3 (E543-3), SIVsmH635FC (H635FC), SIVmac239 (mac239), or plasma from SIVsmH445-infected
macaques, H635+H631 (plasma).
LDN, lymphadenopathy; GN, glomerulonephritis; SIVE, SIV encephalitis; SIVP, SIV pneumonia; IA, intestinal amyloidosis; LPD, lymphoproliferative disorder.
doi:10.1371/journal.ppat.1000372.t001
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+ T cell decline in SIV infection. (A) Classification of the 20 study macaques as memory depletion (MD) or naı ¨ve
depletion (ND). Naive (blue) and memory (red) CD4
+ T cells in total T cells in PBMC from 20 macaques at death are shown. Naive (CD95
lowCD28
high)
and memory (CD95
highCD28
high and CD95
highCD28
low) subsets of CD4
+ T cells were analyzed by flow cytometry. (B) Comparison of naive/memory
ratio in CD4
+ T cells in PBMC, PLN, and spleen at death. The ratio was compared between ND (n=12) and MD (n=8) in PBMC, ND (n=7) and MD
(n=5) in PLN, and ND (n=11) and MD (n=7) in spleen. (C) Naı ¨ve (left) and memory (right) CD4
+ T cell counts in blood pre-inoculation (pre) and at
death. The absolute cell numbers of ND (n=12) and MD (n=8) macaques at death were compared by nonparametric Mann-Whitney U test. The cell
numbers pre- and at death were compared by Wilcoxon matched pairs t-test.
doi:10.1371/journal.ppat.1000372.g001
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(Table 1 and Figure 1A). The naı ¨ve to memory ratio of these two
groups of animals differed significantly from one another in
peripheral blood mononuclear cells (PBMC), PLN and spleen at
death (Figure 1B: P=0.0002, 0.0025 and 0.0006), showing much
higher ratios in MD macaques. Comparison of CD4
+ T cell
subsets at pre-inoculation and at death revealed a significant
decline in the memory subset in MD macaques and in both
subsets in ND macaques (Figure 1C). Figure 2A shows flow
cytometric data for a representative macaque of each group.
Animal H723 with naı ¨ve cell depletion showed a fairly normal
representation of subsets in PBMC but preferential depletion of
naı ¨ve CD4
+ T cells in lymphoid tissues, where naı ¨ve cells are
normally abundant in healthy macaques (Figure 2A and 2B).
Conversely, H718, a macaque with primarily memory CD4
+ T
cell depletion showed selective depletion of the CD4
+ memory
Figure 2. Representative flow cytometry and kinetics of CD4
+ T cell loss in ND and MD macaques. (A) CD4
+ T cell subsets of PBMC, PLN,
and spleen of macaques H723 and H718 are shown as representatives of ND and MD macaques, respectively. Naive (CD95
lowCD28
high) and memory
(CD95
highCD28
high and CD95
highCD28
low) subsets of CD4
+ T cells were analyzed by flow cytometry. (B) CD4
+ T cell percentages and their subsets in
various tissues from macaques, H723 (upper) and H718 (lower). Naive (blue) and memory (red) CD4
+ T cells in total T cells are shown. (C) Kinetics of
CD4
+ T cell depletion in H723 (upper) and H718 (lower). Naive (blue dotted line), memory (red), and total (green) CD4
+ T cell counts in blood are
shown.
doi:10.1371/journal.ppat.1000372.g002
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both memory and naı ¨ve CD4
+ T cell populations gradually
declined in H723 during the course of infection, but only the
memory population declined in H718. Due to the predominance
of naı ¨ve cells in peripheral blood in H718, a progressive decline
of total CD4
+ T cells in the chronic phase was only observed in
H723. Similar patterns in the kinetics of naı ¨ve and memory
CD4
+ T cell loss were observed in the remaining animals of
each group. These data were confirmed by examining the
kinetics of CD4
+ T cell declines in 12 individual animals (n=8
ND and n=4 MD) as shown in Figure 3. A progressive loss of
CD4
+ T cells, a slow decline of both naı ¨ve and memory subsets,
was observed in the ND macaques (Figure 3; left panels).
Although a precipitous decline in all CD4 subsets (as well as
CD8
+ T cells and B cells, data not shown) occurred terminally in
many of the MD macaques possibly due to acute regenerative
failure, MD macaques primarily exhibited selective memory
CD4
+ T cell depletion (Figure 3; right panels). Both groups
Figure 3. Comparison of the kinetics of CD4
+ T cell subsets between ND and MD macaques. The kinetics of total (A), naı ¨ve (B), and
memory (C) CD4
+ T cell decline in ND (n=8; left panels) and MD macaques (n=4; right panels). ND macaques show a progressive and relatively slow
decline in all CD4
+ T cell subsets in the blood during the course of infection, although proportionally more naı ¨ve CD4
+ T cells are lost. In contrast, loss
of memory CD4
+ T cell is a prominent feature observed in MD macaques. A precipitous decline in white blood cell counts terminally in MD macaques
results in variable degrees of terminal depletion of total and naı ¨ve CD4
+ T cells.
doi:10.1371/journal.ppat.1000372.g003
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exception of SIVsmH635FC-infected macaques that were all
classified to the ND group (Table 1). Thus, it appears that the
inoculum was not a major factor in determining the type of
disease course.
These two groups of macaques differed significantly in terms of
viral replication and humoral immune responses. As shown in
Figure 4A, plasma viral load at the time of death was significantly
higher in MD than ND macaques. Conversely, anti-SIV specific
antibody titers, as measured by ELISA, were significantly higher in
ND than MD macaques (Figure 4B). The higher viral load, low
antibody responses and profound memory CD4
+ T cell depletion
seen in the MD macaques, are all characteristic of a syndrome of
rapid progression (RP) macaques that is commonly observed in a
subset of macaques infected with pathogenic strains of SIV [25–30].
Consistent with this similarity, MD macaques included five RP
macaques and three macaques with a longer disease course
(Table 1). In contrast, none of the ND macaques were typical
rapid progressors as defined by lack of SIV-specific antibody
responses. However, in at least seven of the ND animals, the disease
course was interrupted prior to the development of opportunistic
infections by adverse events such as thrombosis. SIV-specific
cellular immune responses were not assessed in this cohort but are
likely to provide another potential discriminator between these two
groups since rapid progression is also associated with failure to
maintain SIV-specific CTL responses [30]. The median survival of
the MD group was significantly shorter than the ND group (29.5
and 70.5 weeks respectively, P=0.0135). In terms of pathologic
outcome, opportunistic infections were observed in both ND and
MDmacaques.AsexpectedfromtheassociationofSIVencephalitis
and pneumonia with rapid progression, these findings were more
common in the MD group [25]. A pathologic finding that was
unique to the ND group was the occurrence of thrombosis of major
vessels such as the pulmonary artery, and vena cava; these events
resulted inthe acute death ofsixoftheanimals (H596,H704,H709,
H714, H723 and XGE) in this group.
ND Macaques Show Generalized Immune Activation
Secondary indicators of immune activation such as intestinal
amyloidosis (n=2), generalized lymphadenopathy (n=12) and
lymphoproliferative syndrome (n=1), were commonly observed in
the ND group (Table 1). As a measure of lymphocyte proliferation
in lymph nodes, immunohistochemistry for Ki-67 expression was
performed on sequential lymph node biopsies. As shown in
Figure 5A, this analysis demonstrated increasing proliferation in T
cell areas and the germinal centers of ND macaques. The
development of follicular hyperplasia was a particularly prominent
feature of lymphoid tissue in ND macaques and this was often
accompanied by increasing numbers of B cells in the blood
(Figure 5B). Although immune activation, as indicated by
increased levels of Ki-67
+ CD4
+ T cells, was observed early in
infection in all of the animals, the number of proliferating CD4
+ T
cells, were higher in ND than MD macaques during the chronic
phase of infection (Figure 6A). To examine whether the immune
activation in ND macaques was induced by increased microbial
translocation across the intestinal lumen [19], we measured
lipopolysaccharide (LPS) levels in terminal plasma samples
(Figure 6B). Both the ND and MD animals showed elevated
levels of LPS (mean; 18.6 and 8.8 pg/ml, respectively) as
compared to uninfected rhesus macaque plasma LPS (mean;
1.14 pg/ml). An outlier with extremely elevated LPS resulted from
gram-negative bacterial sepsis (H679). While there was no
statistical significant difference, LPS levels in ND macaques did
trend higher than in MD macaques. The level of soluble CD14,
which is secreted from CD14
+ monocyte/macrophages in
response to chronic LPS stimulation, was also elevated in
both groups (Figure 6C), consistent with significant microbial
translocation in both groups. The lack of proliferation of CD4
+ T
cells in MD macaques terminally suggests that these animals have
lost the ability to respond to LPS stimulation due to profound
immunosuppression.
Autoreactive Antibodies and Autoimmune Sequelae in
ND Macaques
As is also commonly observed in HIV-infection [31,32], many
SIV-infected macaques exhibited thrombocytopenia during their
disease course [33,34]. As shown in Figure 7A, a progressive
decline was observed throughout the course of infection in ND
macaques and the platelet count at the time of death was
significantly lower in ND than MD macaques (Figure 7B).
Antibodies against platelet glycoproteins were detected in ND
macaques more frequently than in MD macaques (Figure 7C).
Similar to immune thrombocytopenia in HIV infection, anti-
GPIIIa was the most frequently observed platelet autoantibody
[31]. Many of the macaques with severe thrombocytopenia died
suddenly due to thrombosis of a major vessel and this finding was
unique to ND macaques. Although such thrombotic events and
associated arteriopathy are commonly associated with chronic
SIV-infection, their etiology is unclear. In HIV-infected patients, a
hypercoagulable state induced by autoantibodies to phospholipid
(aPL) and other clotting factors can lead to thrombotic events [35].
We therefore examined plasma samples from these macaques for
the presence of aPL antibodies. As shown in Figure 7D, a
significant increase in aPL was observed in ND but not MD
macaques. ND macaques also exhibited elevated dsDNA anti-
bodies, suggesting a generalized autoimmune dysregulation in ND
macaques (Figure 7E). Consistent with a functional consequence in
macaques, aPL titers inversely correlated with platelet counts and
aPL titers were significantly higher in macaques with catastrophic
thrombotic events (Figure 7F and 7G).
Association of Progressive CD4
+ T Cell Loss with
Autoreactive Antibodies
The memory CD4
+ T cell loss in MD macaques would appear
to be mainly explained by direct cell killing of CCR5
+CD4
+ target
cells that is compounded by insufficient production [7,8,29]. In
contrast, the loss of naı ¨ve CD4
+ T cells in ND macaques was not
Figure 4. Significant differences in plasma viral load and SIV-
specific antibody responses in ND and MD macaques. (A) Plasma
viral loads at death were compared between ND (n=12) and MD (n=8)
macaques. (B) Anti-SIV antibody titers at death were compared
between ND (n=12) and MD (n=8) macaques by ELISA. Comparisons
were performed using the nonparametric Mann-Whitney U test.
doi:10.1371/journal.ppat.1000372.g004
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PLoS Pathogens | www.plospathogens.org 6 April 2009 | Volume 5 | Issue 4 | e1000372Figure 5. Increased lymphocyte proliferation in lymph nodes and B cell lymphocytosis in ND macaques. (A) Proliferation of
lymphocytes analyzed by immunohistochemistry for Ki-67 expression in lymph node biopsies collected at 1, 4, 16, 36 weeks post-inoculation and
death of a representative ND macaque (H709) and death of a representative MD macaque (H717). Ki-67 staining of proliferating B cells in germinal
centers became increasingly more intense accompanied by an increase in the number Ki-67
+ cells in the paracortex (T cell area). Germinal centers
became larger with time in the ND macaque. This contrasted with the minimal proliferation observed in the lymph nodes of the representative MD
macaque. (B) Analysis of CD20
+ B cells in the blood in ND macaques (n=8) and MD macaques (n=4) showed B cell lymphocytosis in many of the ND
macaques.
doi:10.1371/journal.ppat.1000372.g005
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CXCR4, not CCR5 [11] and SIV strains generally use CCR5 as
their major co-receptor. The emergence of a CXCR4-tropic SIV
has only been observed once in macaques and was associated with
extensive substitutions in the V3 region of Env [29,36]. Similarly,
emergence of X4-tropic SIVs in sooty mangabeys was associated
with changes within the V3 loop [37]. Our prior sequence analysis
of sequential plasma virus from a number of these animals did not
show evolution of this region of Env to X4 tropism [27] (Figure
S2). Therefore we used envelope clones from 20 wpi plasma of two
of these animals (H704 and H709) to evaluate whether emergence
of a X4 variant explained the naı ¨ve CD4
+ T cell depletion
observed in these animals by this time point. Virus pseudotypes
produced by cotransfection of appropriate envelope clones with
pSG3DEnv, a Rev expression plasmid, were assayed for sensitivity
to the CCR5 and CXCR4 antagonists, TAK779 and AMD3100
in TZM-bl cells. As observed in Figure 8, the parental viruses
SIVsmH635 and SIVsmE543-3 and clones derived from two ND
macaques were inhibited only by the CCR5 antagonist, consistent
with maintenance of CCR5 as their major co-receptor. This
contrasted with the expected inhibition of the CXCR4-tropic
HIV-NL4-3 by AMD3100. To validate this finding, we also
evaluated the infection frequency by quantitative real time PCR
for SIV DNA within sorted populations of naı ¨ve and memory
CD4
+ T cells from samples of spleen collected at necropsy of five
of the ND macaques. By this time point, only one sample (H709)
had sufficient naı ¨ve cells (8.8%) for accurate cell sorting and
qPCR. For this sample, the ratio of SIV gag copies per cell
number was 29% of memory CD4
+ T cells versus 5% of naı ¨ve
CD4
+ T cells, consistent with preferential infection of memory
CD4
+ T cells. Hence the emergence of CXCR4-tropic SIV within
ND macaques did not appear to explain the depletion of naı ¨ve
CD4
+ T cells in at least two of these animals. Further more
detailed analysis would be necessary to totally eliminate a role for
X4 viruses.
The heightened immune activation and the propensity for
autoimmune manifestations in the ND macaques led us to explore
the possibility that autoimmune mechanisms might account for the
loss of naive CD4
+ T cells in these animals. We therefore
examined terminal plasma samples for antibodies that bound the
surface of CD4
+ T cells from healthy, uninfected donor macaques.
In addition, terminal CD4
+ T cells of study macaques were
analyzed for surface IgG and IgM. As shown in Figure 9A and 9B,
antibodies that bound CD4
+ T cells were detected exclusively in
plasma or purifed IgG from ND macaques. Moreover, the level of
anti-CD4
+ T cell IgG correlated significantly with B cells count at
Figure 6. Proliferation of CD4
+ T cells and microbial translocation in SIV-infected macaques. (A) Proliferation of CD4
+ T cells was analyzed
by Ki-67 coexpression. Kinetics of percentage of Ki-67
+CD4
+ T cells in ND (blue) and MD (red) macaques are shown with increasing percentages in ND
macaques over the course of infection. (B) Plasma LPS levels were determined in ND (n=12), MD (n=8), and SIV-naı ¨ve (n=10) macaques. LPS levels in
ND and MD macaques at death were significantly higher than naı ¨ve macaques. (C) Plasma levels of sCD14 in ND and MD macaques. LPS and sCD14
levels were compared by nonparametric Mann-Whitney U test.
doi:10.1371/journal.ppat.1000372.g006
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PLoS Pathogens | www.plospathogens.org 8 April 2009 | Volume 5 | Issue 4 | e1000372Figure 7. Autoimmune manifestation and autoantibodies in SIV-Infected macaques. (A) Progressive decline of platelets in the blood in ND
macaques (n=8, left), contrasted with more stable levels in MD macaques (n=4, right). (B) Platelet counts in blood at death were significantly
different between ND (n=12) and MD (n=8) macaques. (C) A trend to higher frequency of anti-platelet antibodies was observed in plasma samples
at death in ND (n=12) as compared to MD (n=8) macaques. (D) Anti-phospholipid (aPL) Ab titers at death were significantly higher in ND (n=12)
than in MD (n=8) macaques. (E) Higher levels of anti-dsDNA Ab titer at death in ND (n=12) versus MD (n=8) macaques. (F) A significant correlation
was observed between aPL titer and platelet count. Platelet count and aPL titer at death were plotted using ND (blue circles, n=12) and MD (red
triangles, n=8) macaques. A linear regression analysis indicated a regression line with a slope=24.6662.17 (R
2=0.204). (G) Anti-phospholipid
antibody titers at death were compared between macaques with thrombosis (n=6) and without thrombosis (n=14). Macaques with thrombosis
showed a significantly higher level of aPL antibodies.
doi:10.1371/journal.ppat.1000372.g007
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Figure 5B). Most importantly, the level of anti-CD4
+ T cell IgG
correlated significantly with a lower naı ¨ve/memory ratio of CD4
+
T cells, an indicator of naı ¨ve depletion (Figure 9D) as well as with
absolute naı ¨ve CD4
+ T cell counts at death (Figure 9E). We next
examined T cells from PBMC samples from ND and MD
macaques for the presence of surface-bound IgG by flow
cytometry. In vivo antibody binding was also exclusively detected
on the surface of CD4
+ T cells from ND macaques, as shown by
representative flow cytometry plots in Figure 10A. The percentage
of CD4
+ T cells with surface IgG was significantly higher in the
ND versus the MD group (Figure 10B). In vivo binding of IgM was
also detected on the CD4
+ T cells from ND macaques, though
there was no significant difference between the two groups
(Figure 10B). Similar to plasma antibodies, a significant inverse
correlation was observed between the percent of IgG
+CD4
+ T
cells and the memory/naı ¨ve CD4
+ T cell ratio (Figure 10C);
macaques with higher anti-CD4
+ T cell antibodies had lower
naı ¨ve/memory ratio, indicative of naı ¨ve CD4
+ T cell depletion.
The kinetics of the development of CD4
+ T cell bound IgG and
IgM were analyzed on cryopreserved PBMC samples (Figure 11).
IgG was detected on the surface of CD4
+ T cells in most of the ND
macaques by eight or 12 wpi, peaking generally around 30 wpi.
The emergence of autoantibodies was coincident with the
development of naı ¨ve CD4
+ cell deletion. IgM was also detected
on CD4
+ T cells but at much lower levels, gradually increasing in
most of ND macaques. Similar results were obtained from the
analyses of CD8
+ T cells; antibodies that bound CD8
+ T cells from
SIV-uninfected macaques were detected in plasma and on the
surface of CD8
+ T cells of ND macaques (Figure 12A) but the
levels were lower than that observed on CD4
+ T cells. Depletion of
naı ¨ve CD8
+ T cells, which is common in HIV-infected patients
[1,2], was specifically observed in ND macaques (Figure 12B),
suggesting that the naı ¨ve subset depletion is associated with
autoreactive antibodies in both T cell populations.
Discussion
In the present study, autoreactive antibodies to platelet
glycoproteins, phospholipids, dsDNA and surface antigens on T
cells were observed in a subset of SIV-infected macaques that
showed primary depletion of naı ¨ve CD4
+ T cells. These antibodies
were associated with pathologic consequences, such as thrombo-
cytopenia, thrombosis and naı ¨ve cell depletion of both CD4
+ and
CD8
+ T cells in blood and tissues. Our data are consistent with a
potential role of these antibodies in CD4
+ T cell depletion in SIV
infection and has additional implications for the pathogenesis of
AIDS in humans.
The defining feature of HIV-associated disease is the slow loss
of CD4
+ T cells in the chronic phase of infection and resulting
immunodeficiency [1–3]. However, a heightened state of
generalized immune activation of T [1,19,20] and B cells
[21,22] is also a prominent feature of HIV-infection. Indeed, the
extent of immune activation in HIV-infection is an independent
indicator of disease progression, as informative as plasma viral
load [20] and CD4
+ T cell counts. Moreover, the extent of
immune activation is a striking difference between pathogenic
and nonpathogenic infections with SIV [23,24]. The exact
mechanisms whereby immune activation contributes to AIDS
progression have not been clearly defined. Immune activation is
presumed to lead to CD4
+ T cell depletion through indirect
mechanisms such as providing new activated CD4
+ T cell targets
and activation-induced apoptosis. Our study provides evidence
that the destruction of CD4
+ T cells by autoreactive antibodies
may be a third mechanism that also exerts its action through
immune activation. Indeed, the extent of immune activation in
HIV/SIV infection has been strongly associated with the
development of autoantibodies and various autoimmune diseases
[31,32,38]. One such study observed a correlation with
autoantibodies to nuclear, smooth muscle, and thyroid antigens
with a lower CD4
+ T cell count and increased mortality,
consistent with prognostic value [38].
Antibodies to an array of self-antigens and resultant autoim-
mune disease manifestations are frequently observed in HIV
infection [31,32,38]. Primary clinical manifestations which have
been observed in HIV-infection include thrombocytopenia,
anemia, systemic vasculitis, Reiter’s syndrome, polyarthritis,
Sjogren’s syndrome and antiphospholipid syndrome (APS) [32].
Autoantibodies and autoimmune diseases have also been demon-
strated in SIV-infected macaques [33,34,39]. In the present study,
we observed an association of anti-platelet and antiphospholipid
antibodies with clinical autoimmune disease, specifically throm-
bocytopenia and APS in macaques. These results suggest that the
production of these antibodies had functional and clinical
consequences in these macaques. The mechanisms proposed for
the generation of autoreactive antibodies in HIV/SIV infection
include the loss of regulatory T cells [40], production of anti-
idiotype antibodies [41], and molecular mimicry of gp120 or gp41
with self antigens [42,43]. All of these implicate immune
activation, especially B lymphocyte hyperactivation with hyper-
gammaglobulinemia [21,22].
The hypothesis that autoimmune mechanisms play a role in
AIDS pathogenesis is not a new idea. Anti-CD4
+ T cell antibodies
were reported soon after identification of AIDS, and a role in
CD4
+ T cell decline was suggested [44–46]. This avenue of
research has not been adequately studied primarily since the field’s
mechanistic focus shifted to the direct effects of the virus on
Figure 8. Viruses from ND macaques use CCR5 as co-receptor.
Co-receptor usage of viruses in ND macaques and parental SIV strains
was analyzed using CCR5 and CXCR4 antagonists, TAK779 and
AMD3100, respectively. TZM-bl cells were incubated with pseudotyped
viruses in the absence or presence of the designated concentration of
antagonist. The mean percentage of the control luciferase activity is
shown with standard errors. Pseudotyped viruses were prepared using
Env of SIVsmH635FC and SIVsmE543-2, and two Env clones each from
H704 and H709. The infection with pseudotyped viruses with Env from
H704 and H709 were inhibited by TAK779, but not AMD3100, similar to
parental SIVsmH635FC and SIVsmE543-3. In contrast, the X4-tropic HIV-
1NL43-3 was inhibited by AMD3100, but not TAK779.
doi:10.1371/journal.ppat.1000372.g008
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+CD4
+ T cells [7–12] and the indirect effects
of immune activation [15–18]. Additionally, although the presence
of these antibodies is not at issue, it has been difficult to clearly
show cause and effect. Several studies have shown an association
between anti-CD4
+ T cell antibodies with CD4 T
+ cell depletion
and disease progression [40,47–49], suggesting the potential
contribution to AIDS pathogenesis. However, none of these
studies have clearly identified the mechanism within, and the
Figure 9. Plasma antibodies autoreactive to CD4
+ T cells in ND macaques. (A) Antibodies against CD4
+ T cells were analyzed using plasma
and purified IgG from infected macaques. PBMC from SIV-uninfected macaques were incubated with plasma (5-fold–diluted, blue line) or purified IgG
(1.5 mg/ml, red line) from ND (H709, left) or MD (H718, right) macaques, and stained with antibodies against monkey IgG (FITC), CD3 (PerCP-Cy5.5),
and CD4 (APC). A histogram of monkey IgG is shown after gating CD3
+CD4
+ cells. Dashed line; IgG reactivity of untreated PBMC. (B) Autoantibodies in
terminal plasma samples were compared among ND (n=12), MD (n=8), and SIV-naı ¨ve (n=8) macaques. Percentages of IgG
+ cells in CD4
+ T cells
were determined by the Overton cumulative histogram subtraction using untreated PBMC as a control. (C) Correlation between autoantibodies to
CD4
+ T cells in plasma and B cell count in blood at 16 wpi. Percentages of IgG
+ cells in CD4
+ T cells and B cell counts were plotted using ND (blue
circles, n=8) and MD (red triangles, n=4) macaques. A linear regression analysis indicated a regression line with a slope=0.01260.003 (R
2=0.572).
(D) Correlation between autoantibodies to CD4
+ T cells in plasma and log naı ¨ve/memory ratio in CD4
+ T cells at death. Percentages of IgG
+ cells in
CD4
+ T cells and log naı ¨ve/memory ratio in CD4
+ T cells were plotted using ND (blue circles, n=12) and MD (red triangles, n=8) macaques. A linear
regression analysis indicated a regression line with a slope=220.564.04 (R
2=0.588). (E) Correlation between autoantibodies to CD4
+ T cells in
plasma and log naı ¨ve CD4
+ T cell number at death. Percentages of IgG
+ cells in CD4
+ T cells and log absolute naı ¨ve CD4
+ T cell number were plotted
using ND (blue circles, n=12) and MD (red triangles, n=8) macaques. A linear regression analysis indicated a regression line with a
slope=216.566.97 (R
2=0.237).
doi:10.1371/journal.ppat.1000372.g009
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+ T cells that is depleted. Our study demonstrated
an association of anti-CD4
+ T cell antibodies with loss of naı ¨ve
CD4
+ T cells, which is responsible for the progressive CD4
+ T cell
decline during chronic SIV/HIV infection. This suggests that the
induction of anti-CD4
+ T cell antibodies is one of the important
factors causing a slow depletion of CD4
+ T cells over the long
asymptomatic period leading to AIDS. This mechanism probably
dominates during the earlier and mid stages of HIV infection
when the immune system is highly dysregulated but prior to the
onset of severe immunodeficiency.
Potential mechanisms by which antibodies could mediate CD4
+
T cell loss including complement-mediated lysis, phagocytosis or
antibody-dependent cell-mediated cytotoxicity [45,47,50] will
require evaluation in these animals. In addition, autoantibodies
may affect the production and differentiation of naı ¨ve T cells in
thymus and bone marrow [4,51,52]. Since autoantibodies were
specifcially associated with the loss of naı ¨ve CD4
+ T cells rather
than memory cell, this represents a distinct mechanism from the
recently reported decline of the central CD4
+ T cell pool, which is
also an important subset for maintaining CD4
+ T cells [29,53].
Figure 10. Autontibodies on the surface of CD4
+ T cells in ND macaques. (A) Autoantibodies on the surface of CD4
+ T cells from ND (H709,
left) and MD (H718, right) macaques in representative flow cytometric analysis. Frozen PBMC samples at death were stained with antibodies against
CD4 (FITC), human IgG (PE), 7-AAD (PerCP), and CD3 (APC). Autoantibodies were examined by anti-IgG reactivity (blue) on the surface of live CD4
+ T
cells (7-AAD
2CD3
+CD4
+). Dashed line, staining with IgG1 isotype control (PE) instead of anti-human IgG (PE). (B) The percent of autoantibody positive
CD4
+ T cells at death were compared between ND (n=8) and MD (n=4) macaques. Percentages of IgG
+ (left) or IgM
+ (right) CD4
+ T cells were
determined by the Overton cumulative histogram subtraction using a mouse IgG1 isotype control. (C) Correlation between autoantibodies on CD4
+ T
cells and log naı ¨ve/memory ratio in CD4
+ T cells at death. Percentages of IgG
+ cells in CD4
+ T cells and log naı ¨ve/memory ratio in CD4
+ T cells were
plotted using ND (blue circles, n=8) and MD (red triangles, n=4) macaques.
doi:10.1371/journal.ppat.1000372.g010
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+ and CD8
+ T cells in this
study and HIV-1-infected patients [1,2] also suggests that the
mechanism for the decline and the self antigens involved may be
common to both T cells. Another autoimmune mechanism not
evaluated in the present study, was the generation of autoreactive
CD8
+ T cells primed by the release of protein fragments from
apoptotic CD4
+ T cells [54]. MHC alleles may be critical to the
induction of autoreactive antibodies, as indicated in a number of
autoimmune diseases [55] but were not assessed in this study.
Although further studies are required to define the contribution
of autoantibodies to AIDS pathogenesis, our study suggests that
such antibodies may act in concert with other mechanisms of
CD4
+ T cell loss, such as immune activation induced cell death
and destruction of the lymphoid architecture [15–18]. Our data
are consistent with a potential role of these antibodies in CD4
+ T
cell depletion in SIV infection and has additional implications for
the pathogenesis and treatment of AIDS in humans.
Methods
Animals and Viruses
Rhesus macaques (Macaca mulatta) of Indian origin were
inoculated with molecularly cloned virus stocks generated by
transfection of 293T cells, (SIVsmE543-3, SIVsmH635FC,
SIVmac239), a combination of SIVsmE543-3 and
SIVsmH635FC, or terminal plasma samples from two
SIVsmH445-infected macaques, H631 and H635 [6,26–28].
Twenty SIV-infected macaques used in this study consist of the
9 macaques from Kuwata et al. [27], 8 macaques from Nishimura
et al. [6], and 3 macaques infected with plasma from SIVsm-
infected macaques. Our criteria for inclusion in the study were
lack of prior treatment or vaccination and the availability of
terminal blood samples for analysis. EDTA-anti-coagulated blood
samples were collected sequentially to examine plasma viral RNA
load and lymphocyte subsets. Tissue samples, such as jejunum,
ileum, colon, lung, PLN and spleen, were obtained at death from a
subset of the animals. Lymphocytes were isolated from the blood,
spleen and PLN by Ficoll gradient, and by collagenase treatment
from jejunum, ileum, colon and lung [27]. The viral RNA loads in
plasma were determined by real-time reverse transcriptase-PCR
(RT-PCR) using a Prism 7700 sequence detection system (Applied
Biosystems, Foster City, CA), as previously described [27]. All
animals were housed in accordance with American Association for
Accreditation of Laboratory Animal Care standards. The
investigators adhered to the Guide for the Care and Use of
Laboratory Animals prepared by the Committee on Care and Use
of Laboratory Animals of the Institute of Laboratory Resources,
National Resource Council, and the NIAID Animal Care and Use
Committee-approved protocols.
Determination of Co-Receptor Usage of Viruses
Co-receptor usage of viruses infecting ND macaques and
parental SIV strains was analyzed using CCR5 and CXCR4
antagonists, TAK779 and AMD3100 [56–60]. The Env gene was
amplified from plasma samples of H704 and H709 at 20 wpi, and
cloned into the expression vector, pcDNA3.1/V5-His TOPO
(Invitrogen, Carlsbad, CA), as described [26]. Pseudotyped viruses
were prepared by cotransfection of 293T cells with pSG3DEnv,
Rev expression plasmid and Env expression plasmid using
Lipofectamine 2000 (Invitrogen) [61,62]. After a 1 h incubation
of 40 ml of 2.5610
6 TZM-bl cells [62–64] in the absence or
presence of 10 ml of designated concentration of antagonist in 96
well-plate, 45 ml of pseudotyped viruse and 5 ml of 1.875 mg/ml
DEAE dextran were added. After over night incubation, 100 ml
fresh medium was added to wells. Luminesence was measured
after 2 days using Luciferase Assay System (Promega, Madison,
Figure 11. The kinetics of induction of antibodies autoreactive to CD4
+ T cells. Kinetics of IgG (upper) and IgM (lower) on the surface of
CD4
+ T cells from ND (left, n=8) and MD (right, n=4) macaques are shown graphically. Frozen PBMC samples were stained with antibodies against
CD4 (FITC), human IgG, IgM, or IgG1 isotype control (PE), 7-AAD (PerCP), and CD3 (APC). Percentages of IgG
+ or IgM
+ cells in live CD4
+ T cells (7-
AAD
2CD3
+CD4
+) were determined by the Overton cumulative histogram subtraction using mouse IgG1 isotype control.
doi:10.1371/journal.ppat.1000372.g011
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Bad Wildbad, Germany). Infection was performed in triplicate and
data expressed as the mean. The following reagents were obtained
through the NIH AIDS Research and Reference Reagent
Program, Division of AIDS, NIAID, NIH: TAK779, AMD3100,
pSG3DEnv and TZM-bl cells.
Flow Cytometric Analysis
Phenotypic analysis of T cells was performed by flow cytometry
(FACSCalibur; BD Biosciences, Franklin Lakes, NJ) using FITC,
PE, PerCP-Cy5.5 or APC-conjugated monoclonal antibodies
against CD3, CD4, CD8, CD28 and CD95 (BD Biosciences), as
described [6,27]. Percentages of naive and memory subsets in
CD4
+ or CD8
+ T cells were determined using CD28 and CD95.
Live cells were gated using 7-AAD in the analyses of viably-frozen
cells. Immunoglobulin on the surface of cells was detected by PE-
conjugated antibodies against human IgG or human IgM with a
mouse IgG1 isotype-matched control (BD Biosciences). Since
histograms of a control and experimental samples were overlap-
ping, the percentages of IgG
+ or IgM
+ cells were determined by
the Overton cumulative histogram subtraction, using mouse IgG1
isotype control [65]. To detect antibodies to T cells in the plasma,
PBMC from SIV-uninfected rhesus macaques (5610
5 cells in 50
ml) were incubated for 1 hr at 4uC with 50 ml of plasma (1:5
dilution with PBS) or purified IgG (1.5 mg/ml) from SIV-infected
macaques, washed twice with PBS supplemented with 0.1%
bovine serum albumin, and stained with antibodies against
monkey IgG (FITC), CD3 (PerCp-Cy5.5) and CD4 (APC).
Figure 12. Antibodies autoreactive to CD8
+ T cells and decline of naı ¨ve CD8
+ T cells in ND macaques. (A) Autoantibodies against CD8
+ T
cells in plasma (left) were analyzed using CD4
2 T cells, and were compared among ND (n=12), MD (n=8), and SIV-uninfected (n=8) macaques, as
described in Figure 9. Autoantibodies on the surface of CD8
+ T cells (right two panels) were analyzed using CD8
+ T cells, and were compared between
ND (n=8) and MD (n=4) macaques, as described in Figure 10. (B) Naive and memory CD8
+ T cell count in blood at death. The absolute numbers of
cells were compared between ND (n=8) and MD (n=4) macaques, as described in Figure 1C.
doi:10.1371/journal.ppat.1000372.g012
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OH) was used to detect antibodies in plasma. IgG was purified
from plasma samples by Nab Protein G Spin Kit (Thermo Fisher
Scientific, Rockford, IL). The percentages of IgG
+ cells in CD4
+ T
cells were determined by the Overton cumulative histogram
subtraction using untreated controls. Data analysis was performed
using Flowjo (TreeStar, San Carlos, CA).
Detection of Antibodies to SIV and Autoantigens
Anti-SIV antibody titers were determined by enzyme immuno-
assay (EIA), Genetic Systems HIV2 EIA (Bio-Rad Laboratories,
Hercules, CA) using serial dilution of plasma samples. Antibodies
against three glycoproteins on platelet, GPIIb/IIIa, GPIa/IIa and
GPIb/IX, were determined by EIA, PAKAUTO (GTI Diagnos-
tics, Waukesha, WI). Antibodies (IgG) against phopholipid in
plasma samples were quantified by anti-phopholipid screen IgG/
IgM (ORGENTEC Diagnostika GmbH, Mainz, Germany), which
detects antibodies against cardiolipin, phosphatidyl inositol,
phosphatidic acid and ß2-glycoprotein I. Antibodies (IgG) against
double-stranded DNA were quantified by anti-dsDNA (ORGEN-
TEC Diagnostika GmbH).
Measurement of Lipopolysaccharide (LPS) and sCD14
Plasma levels of LPS were measured by the Chromogenic end
point Limulus amebocyte kit (Cambrex, Charles City, IA) as
recommended by the manufacturer. A commercially available
ELISA was used to quantify plasma levels of sCD14 (R&D
Systems, Minneapolis, MN); each ELISA was performed in
duplicate according to the manufacturer’s protocol.
Cell Sorting of Memory and Naı ¨ve CD4
+ T Cells and
Quantitative PCR
Cell sorting was accomplished using a FACS Aria cell sorter
(BDIS) at 70 lb/in2. FITC, PE, Cy5 PE, and APC were used as
the fluorophores. At least 10,000 cells were sorted for PCR and
reverse transcriptase PCR analysis. Sorted populations were
consistently at least 99.8% pure. Quantification of SIV gag
DNA in sorted CD4
+ T cells was performed by quantitative PCR
by means of a 59 nuclease (TaqMan) assay with an ABI7700
system (Applied Biosystems) as previously described [66]. To
quantify cell number in each reaction, qPCR was performed
simultaneously for albumin gene copy number as previously
described [67]. Standards were constructed for absolute quanti-
fication of gag and albumin copy number and were validated with
sequential dilutions of 8E5 cell lysates that contain one copy of gag
per cell. Duplicate reactions were run and template copies
calculated using ABI7700 software.
Immunohistochemistry
Ki-67 expression was assessed in formalin-fixed, paraffin-
embedded lymph node samples by immunohistochemical staining
as previously described [68]. Samples were incubated with
monoclonal antibody against Ki-67 (Dako, Glostrup, Denmark)
and goat anti-rabbit immunoglobulin G-Alexa fluor 488 (Invitro-
gen). The stained sections were rinsed, counterstained with
hematoxylin, covered, and photographed with a Zeiss Axiophot
microscope.
Statistical Analysis
All statistical analyses were performed with Prizm (GraphPad
Software, La Jolla, CA). ND and MD macaques were compared
by nonparametric Mann-Whitney U test. Correlation analysis and
linear regression analysis were performed between IgG
+ percent-
age and log naı ¨ve/memory ratio or the naı ¨ve CD4
+ T cell count.
Supporting Information
Figure S1 Flow cytometric analysis of peripheral blood
lymphocytes (PBMC), peripheral lymph node (PLN), and spleen
samples collected at death. Naive (CD95
lowCD28
high) and memory
(CD95highCD28
high and CD95
highCD28
low) subsets of CD4
+ T
cells were analyzed by flow cytometry. Plots from six additional
ND macaques (in addition to Figure 2) and two additional MD
macaques demonstrate the preferential depletion of naı ¨ve CD4
+ T
cells and memory CD4
+ T cells in ND and MD macaques,
respectively.
Found at: doi:10.1371/journal.ppat.1000372.s001 (0.62 MB EPS)
Figure S2 Sequence alignment of the V3 loop analog of SIV in
ND macaques inoculated with a molecularly cloned virus,
SIVsmH635FC at 20 weeks (A) and later time points (B). Clones
derived from plasma of ND macaques were compared to the CCR5
using viruses, the parental SIVsmH635FC, SIVsmE543-3, and
SIVmac239 aswellastheonlyreported CXCR4-using SIVmac/sm
clone, SIVmac155T3. Amino acid substitutions are shown relative
to SIVsmE543-3, conserved amino acids are indicated by a dot (.),
and gaps inserted to maximize alignment are indicated by a dash (-).
The virus inoculum and most of the clones have substitution in the
V3 loop relative to SIVsmE543-3 at position 337, which is not
associated with a switch in co-receptor usage.
Found at: doi:10.1371/journal.ppat.1000372.s002 (1.53 MB EPS)
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